Engineering biomimetic bone marrow niche with gene modified mesenchymal stromal cells for ex vivo culture of human hematopoietic stem and progenitor cells
Abstract Background Hematopoietic Stem and Progenitor Cells (HSPCs) gene therapy has shown significant progress, with commercial approval for at least four distinct haematological disorders, and poised for a rapid expansion in the upcoming years. Despite these advancements, the ex vivo culture of HS...
Saved in:
| Main Authors: | Sevanthy Suresh, Vigneshwaran Venkatesan, Manoj Kumar K. Azhagiri, Gokulnath Mahalingam, Prathibha Babu Chandraprabha, Mohankumar K. Murugesan, Sanjay Kumar, Saravanabhavan Thangavel, Srujan Marepally |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-025-04474-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sickle cell disease: understanding pathophysiology, clinical features and advances in gene therapy approaches
by: Muhammad Taher, et al.
Published: (2025-08-01) -
Surface Molecules Involved in Avian T-Cell ProgenitorMigration and Differentiation
by: C. Ody, et al.
Published: (2000-01-01) -
Endothelial progenitor cells in diabetes complications
by: Marina Cergeevna Michurova, et al.
Published: (2015-03-01) -
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next‐generation human artificial chromosomes for Duchenne muscular dystrophy
by: Sara Benedetti, et al.
Published: (2017-12-01) -
Post-thaw dimethyl sulfoxide reduction in autologous peripheral blood progenitor cell suspensions
by: Miroslava Jandová, et al.
Published: (2025-10-01)